Chiome Bioscience Inc.
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Chiome Bioscience Inc. made a loss over the last year. Chiome Bioscience Inc. owes ¥0.18 for every ¥1 it owns. Chiome Bioscience Inc. made a loss in each of the last two years.
Compared with Healthcare companies in Japan · latest annual results Dec 2025.
P/E ratio
LossChiome Bioscience Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
4.77The share price is 4.77 times Chiome Bioscience Inc.'s book value per share, higher than 86% of Healthcare companies in Japan.
Market cap
¥7.5 BThe total market value of all of Chiome Bioscience Inc.'s shares at today's price (share price × number of shares), smaller than 67% of Healthcare companies in Japan. PosiCap size class: Micro Cap.
Net worth (book value)
¥1.6 BWhat Chiome Bioscience Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
¥19.30Net worth divided by the number of shares. The share price of ¥92.00 is 4.8 times this, which is the P/B above.
Return on equity (ROE)
-60.0%Chiome Bioscience Inc. lost 60.0% of its shareholders' money over the last year, lower than 89% of Healthcare companies in Japan.
Owes vs Owns
0.18×Chiome Bioscience Inc. owes ¥0.18 for every ¥1 it owns (low), lower than 81% of Healthcare companies in Japan.
Dividend yield
NoneChiome Bioscience Inc. does not currently pay a dividend.
Revenue growth
-24%Revenue fell 24% in the year to Dec 2025, and shrank 2% a year on average over 3 years.
Profit growth
LossChiome Bioscience Inc. made a loss in each of the last two years.
Profit margin
-165.6%Chiome Bioscience Inc. lost ¥166 for every ¥100 of revenue.
Interest cover
Not coveredChiome Bioscience Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net cashChiome Bioscience Inc. held ¥943 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Chiome Bioscience Inc.: ¥7.5 B ÷ ¥1.6 B (30 Jun 2026) = 4.8.
What is Chiome Bioscience Inc.'s return on equity?
Chiome Bioscience Inc. lost 60.0% of its shareholders' money over the last year, lower than 89% of Healthcare companies in Japan.
How much does Chiome Bioscience Inc. owe compared with what it owns?
Chiome Bioscience Inc. owes ¥0.18 for every ¥1 it owns (low), lower than 81% of Healthcare companies in Japan.
Does Chiome Bioscience Inc. pay a dividend?
No. Chiome Bioscience Inc. does not currently pay a dividend.
Is Chiome Bioscience Inc.'s revenue growing?
Revenue fell 24% in the year to Dec 2025, and shrank 2% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.